Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
Clinical trial NCT05427669 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05427669
- Sponsor
- Yanhong Deng
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-09
- Primary completion
- 2025-07-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.